Recent executive movements at Bristol-Myers Squibb

Nadim Ahmed who was President, Hematology and Oncology, Celgene, becomes President, Hematology  (news posted on November 21 2019).
David Elkins, who was Executive Vice President and Chief Financial Officer, Celgene, is promoted to Executive Vice President and Chief Financial Officer  (news posted on November 21 2019).
Phyllis Yale will join the company as Director in Dec. 2019  (news posted on November 21 2019).

Click here to view some more movements at Bristol-Myers Squibb

Create an alert
to follow the executive moves at Bristol-Myers Squibb Japan.

Latest M&A news in Pharmaceuticals.

Novartis has announced the acquisition of Medicines (posted on Nov 27, 2019).
Glaukos has acquired Avedro (posted on Nov 22, 2019).
Bristol-Myers Squibb has acquired Celgene (posted on Nov 21, 2019).

Most searched biographies at Bristol-Myers Squibb Japan

• Jean-Christophe Barland, Chief Executive Officer
• Isamu Furosako, IT Director
• Catherine Ohura, Executive Officer and Unit Head, Commercial Opera...

Click on an executive to view his biography >

Other contacts in the Pharmaceuticals industry

• Thomas Wozniewski - Senior Vice President, Global Senior Vice President, Global Manufacturing Officer at Takeda Pharmaceutical
• Lionel Viret - Chairman of the Board at Groupe Stago
• Claudio Bergamo dos Santos - Chief Executive Officer at Hypermarcas

Learn more about the Pharmaceuticals industry >

Latest news about Bristol-Myers Squibb Japan

Bristol-Myers Squibb Japan on Wikipedia, Google News & Yahoo Finance

Bristol-Myers Squibb Japan on LinkedIn, Twitter & YouTube

Bristol-Myers Squibb Japan has 1,958 competitors including Johnson & Johnson (United States (USA)), Roche (Switzerland) and Pfizer (United States (USA)). Bristol-Myers Squibb Japan is owned by Bristol-Myers Squibb APAC.

Contact by email its executives including Jean-Christophe Barland

Call Bristol-Myers Squibb Japan at +81 35....

View the org chart

Register to receive your alert

Report an error